Navigation Links
Chris Tihansky Appointed President of In Vivo Cellular Imaging Leader Cellvizio Inc.
Date:2/13/2008

- Company Establishes U.S. subsidiary in Philadelphia Area -

PHILADELPHIA, Feb. 13 /PRNewswire/ -- Cellvizio Inc., a leader in in vivo cellular imaging, announced today the appointment of Chris Tihansky as its President. Cellvizio Inc. is the U.S. subsidiary of Paris-based Mauna Kea Technologies and develops and markets Cellvizio(R), a fundamentally new endoscopic imaging approach which improves patient care by eliminating the need for unnecessary biopsies and enhances the diagnosis of a broad range of diseases via in vivo cellular imaging.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080213/NYW021 )

The appointment coincides with the company establishing its U.S. operations base in the Philadelphia area.

"Cellvizio is increasing its commercialization efforts in the U.S., and Chris is a great fit for leading this," said Sacha Loiseau, Ph.D., founder, president and chief executive officer of Mauna Kea. "He has a unique combination of expertise in the medical technology field, including general management, business development, sales, and product development."

"Cellvizio is an excellent example of a company that has successfully taken a cutting-edge technology from bench top to bedside," explained Chris. "I am very pleased to be leading our team in the U.S. It is our intention to make Cellvizio a standard of care so that as many patients as possible have access to the advantages this technology offers."

"The Philadelphia area is a perfect location for us to rapidly build our business," Chris stated. "It offers ready access to our customer base and a strong talent pool. Additionally, it is increasingly evident that Southeastern Pennsylvania offers a well-developed support infrastructure for emerging med- tech companies."

Chris has 20 years of experience in the emerging medical technology and healthcare financials services industri
'/>"/>

SOURCE Cellvizio Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants
2. Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors
3. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
4. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
5. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
6. Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
7. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
8. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
9. David Mott Appointed Non Executive Director at Shire
10. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
11. John Marshall and Kevin McGuinness Appointed to Ellex Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...CET, AMSTERDAM, February 20 Amsterdam Molecular,...d of human gene therapy,today reported its full ye..., raising gross proceeds of EUR 55.7 million - Ca...30, 2007 - U.S. FDA orphan drug designation for l.../II in LPL type I deficiency - Pre-registration t...
...emonstrated by a collaboration between researchers...logy (NIST), Penn State and the University of Kent...duce large arrays of organic electronic transistor...ns including flexible displays, intelligent paper ...diagnostics. , In a paper posted this week,* the ...
...ion,(Nasdaq: KNSY ) is scheduled to present at th... at the Mission Bay Conference Center in San,Franc..., Kensey Nash,s Chief Operating Officer, will deli...ately at 2:50 p.m. (PT). The,presentation material...p://www.kenseynash.com ) beginning at 2:50 p.m. (P...
Other Biology Technology:Amsterdam Molecular Therapeutics Reports Full Year Results 2007 2Amsterdam Molecular Therapeutics Reports Full Year Results 2007 3Amsterdam Molecular Therapeutics Reports Full Year Results 2007 4Amsterdam Molecular Therapeutics Reports Full Year Results 2007 5Amsterdam Molecular Therapeutics Reports Full Year Results 2007 6Amsterdam Molecular Therapeutics Reports Full Year Results 2007 7Directed self-ordering of organic molecules for electronic devices 2
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 1Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 2Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 3News brief 3A Effects of aspirin and folic acid on inflammation markers for colorectal adenomas 59312 1Drop in Certain Visual Skills May Precede Alzheimers 59310 1Drop in Certain Visual Skills May Precede Alzheimers 59310 2
...pression of genes may be the reason why people who...ckly develop a tolerance, biologists at The Univer...eam, led by graduate student Yan Wang, used the fr...to determine how the nervous system becomes tolera...The team,s work appears in the October 16 issue of...
...ore acid, with potentially devastating consequence...eefs and provide much of the Earths breathable oxy...up of carbon dioxide (CO 2 ) in the atmosphere, di... be lethal for animals with chalky skeletons which...ife. , Acid oceans will be among the issues explo...
...DED BROKERAGE TO UTILIZE TITANIUM,S ... Oct. 16 Titanium Group, Ltd,(OTC Bulletin Board:...s,provider announced today that it has signed a co...) (SHA: 600837). Titanium will install its,Biometr...ated office in,Hong Kong. Haitong, listed in the S...
Other Biology News:Tolerance to inhalants may be caused by changes in gene expression 2Acid oceans warning 2Titanium Group Announces Contract With Haitong Securities 2Titanium Group Announces Contract With Haitong Securities 3Titanium Group Announces Contract With Haitong Securities 4
Mouse Anti-Human ACP2 Monoclonal Antibody, Unconjugated, Clone M1-4A12 from Novus Biologicals
Mouse Anti-Human DCAMKL2 Monoclonal Antibody, Unconjugated, Clone 2A5 from Novus Biologicals
...ew IKATUBE ULTRA TURRAX Tube Disperser System from... system. It offers a cleaner, safer, and more effi...processes sample volumes from 2 to 15 ml inside se...chers can choose one of 4 different tube types. Ea...
...ewest member of Wyatt Technology's family of light...our high temperature chromatograph and enables you...rmoplastic polymers. The HTmD is easily installed ... 2000 device and enables you to get three angles o...
Biology Products: